about
Study on the prevalence and neonatal lethality in patients with selected congenital anomalies as per the data of the National Registry of Congenital Anomalies of Argentina.Public health approach to birth defects: the Argentine experience.The use of a Toolkit for health needs assessment on neural tube defects in ArgentinaDescriptive study on neural tube defects in Argentina.Acitretin embryopathy: a case report.Rubella vaccination of unknowingly pregnant women during 2006 mass campaign in Argentina.RENAC: National Registry of Congenital Anomalies of Argentina.Methimazole embryopathy: a contribution to defining the phenotype.Surveillance of microcephaly and selected brain anomalies in Argentina: Relationship with Zika virus and other congenital infections[Prevalence of neural tube defects and estimation of cases averted in the post-fortification period in Argentina]Esophageal atresia and prenatal exposure to mycophenolateMethotrexate embryopathy after exposure to low weekly doses in early pregnancyChoanal atresia associated with maternal hyperthyroidism treated with methimazole: A case-control studyCenso de servicios de genética médica en ArgentinaChoanal atresia associated with prenatal methimazole exposure: Three new patients[Acheiropodia: first case report in Argentina][Misoprostol teratogenicity: a prospective study in Argentina]A proposal for the systematic assessment of data quality indicators in birth defects surveillanceApplication of quality indicators to data from the National Network of Congenital Anomalies of Argentina[Birth prevalence of Down syndrome in Argentina]
P50
Q30980244-246BD1D8-E494-41E8-9D68-04A4BF8B1D61Q35168667-93A55D57-F27E-461D-831E-0AD8AB2A8DC3Q36511348-36EB6678-5AF4-4F72-9196-CDB2A27C98B4Q41099350-EF80BEC9-19E9-42E4-BF87-0020BB756419Q41920942-E573417F-EF65-490D-9902-8A12E62724D9Q43817663-99D5CDC8-BDD4-461B-9CB9-8C898A1663FFQ51229496-491DCE65-D4CF-4A18-A9FC-3802A7293999Q51997183-6C729EFB-6BA8-4ABA-885E-88A1F0A4F829Q56346027-5BA5C1C9-1A5E-43E3-9247-1A9D39E4F945Q57863659-FE77FEFA-00C6-444C-A535-B16CAA3EF1A1Q57863717-D7C443D9-4C72-4080-BED3-3EB06936BBFCQ57863732-24F6F0D3-A69D-4044-855A-100024232718Q57863797-37E3E143-5E40-4149-BF3D-21D68EE8BB87Q57863826-4DC0FAC6-863F-4DEF-822C-1F6FC4275F4BQ57863853-D4E842F3-7B80-4620-9ADB-5ED315900073Q64049129-6A171587-D746-4D76-9796-FA66C0F9D6E0Q84325413-C89413AD-2A8F-4370-9CCB-493C667EB22AQ91474434-5728CD41-AEAB-40CA-9690-2799F18AD4B9Q91526705-33D87220-8434-4399-9B49-95A83E8B1375Q92313244-17FEB99D-0535-481C-A466-450F8FECA375
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pablo Barbero
@ast
Pablo Barbero
@en
Pablo Barbero
@es
Pablo Barbero
@nl
type
label
Pablo Barbero
@ast
Pablo Barbero
@en
Pablo Barbero
@es
Pablo Barbero
@nl
prefLabel
Pablo Barbero
@ast
Pablo Barbero
@en
Pablo Barbero
@es
Pablo Barbero
@nl
P106
P21
P31
P496
0000-0002-6026-744X